Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 1: Acquired Resistance to Checkpoint Inhibitors

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Plenary Session 1: Acquired Resistance to Checkpoint Inhibitors
Resistance to PD-1 blockade in melanoma
Antoni Ribas
UCLA Medical Ctr., Los Angeles, CA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
Plenary Session 1: Acquired Resistance to Checkpoint Inhibitors
  •  
  • Permission not
    granted for presentation
  •  
  •  
Resistance to PD-1 blockade in MSI-H tumors
Luis A. Diaz
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
Plenary Session 1: Acquired Resistance to Checkpoint Inhibitors
Genomic and neoantigen landscape of response and resistance to immune checkpoint blockade
Victor E. Velculescu
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
Plenary Session 1: Acquired Resistance to Checkpoint Inhibitors
Inactivation of DNA repair to improve immune surveillance
Alberto Bardelli
Univ. of Turin School of Medicine, Candiolo, Italy
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4